Mobia Medical went public but saw its shares drop over 20% on the first day, reflecting investor caution. The company’s Vivistim Paired VNS system targets the stroke recovery market, with revenues expected to double to $32 million by 2025. However, operating losses are also projected to nearly double, raising concerns about profitability. Despite a strong cash position and sales growth, high costs and lack of operating leverage keep investors hesitant, with some waiting for clearer signs of sustained commercial success before investing.
Borgarting Court of Appeal has ruled against the petition by DNB Bank ASA, Swedbank AB, and Danske Bank to seize certain assets of Havila Shipping ASA. This dismissal means Havila Shipping retains control over the disputed assets, which could impact ...
Borgarting Court of Appeal in Norway has denied the request by DNB Bank, Swedbank, and Danske Bank to arrest assets of Havila Shipping ASA. This decision follows earlier filings by the banks seeking to secure claims against the company. The ruling me...
The global insurance analytics market is projected to grow from USD 17.60 billion in 2025 to USD 72.39 billion by 2035, at a CAGR of 15.19%. Growth is fueled by the adoption of AI, cloud computing, and big data, which help insurers reduce fraud, unde...
The number of companies announcing Bitcoin treasury strategies is growing rapidly, driven by market hype and branding rather than genuine financial management. Investors are urged to differentiate between credible firms with transparent, board-approv...
Bitcoin is showing signs of weakening momentum as traders have wiped over $10 billion from the market this week, pushing the price closer to the $70k support level. Sentiment has dropped into extreme fear, a historical sign of capitulation, while mor...
